🇺🇸 FDA
Patent

US 10350306

Methods and compositions for treating genetically linked diseases of the eye

granted A61KA61K31/5377A61K31/573

Quick answer

US patent 10350306 (Methods and compositions for treating genetically linked diseases of the eye) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/5377, A61K31/573, A61K31/592, A61K31/593